Format

Send to

Choose Destination
Eur Radiol. 2019 Jan 28. doi: 10.1007/s00330-018-5975-0. [Epub ahead of print]

Pilot study of rapid MR pancreas screening for patients with BRCA mutation.

Author information

1
Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.
2
Department of Radiology, University of Cagliari, Cagliari, Italy.
3
Department of Radiology, Università Politecnica delle Marche, Ancona, Italy.
4
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
5
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
6
GE Healthcare, Global MR Applications and Workflow, New York, NY, USA.
7
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
8
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
9
Policlinico Umberto I, Department of Radiology, Sapienza University of Rome, Rome, Italy.
10
IRCCS SDN, Naples, Italy.
11
Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA. mannellilorenzo@yahoo.it.

Abstract

PURPOSE:

To develop and optimize a rapid magnetic resonance imaging (MRI) screening protocol for pancreatic cancer to be performed in conjunction with breast MRI screening in breast cancer susceptibility gene (BRCA)-positive individuals.

METHODS:

An IRB-approved prospective study was conducted. The rapid screening pancreatic MR protocol was designed to be less than 10 min to be performed after a standard breast MRI protocol. Protocol consisted of coronal NT T2 SSFSE, axial NT T2 SSFSE and axial NT rFOV FOCUS DWI, and axial T1. Images were acquired with the patient in the same prone position of breast MRI using the built-in body coil. Image quality was qualitatively assessed by two radiologists with 12 and 13 years of MRI experience, respectively. The imaging protocol was modified until an endpoint of five consecutive patients with high-quality diagnostic images were achieved. Signal-to-noise ratio and contrast-to-noise ratio were assessed.

RESULTS:

The rapid pancreas MR protocol was successfully completed in all patients. Diagnostic image quality was achieved for all patients. Excellent image quality was achieved for low b values; however, image quality at higher b values was more variable. In one patient, a pancreatic neuroendocrine tumor was found and the patient was treated surgically. In four patients, small pancreatic cystic lesions were detected. In one subject, a hepatic mass was identified and confirmed as adenoma by liver MRI.

CONCLUSION:

Rapid MR protocol for pancreatic cancer screening is feasible and has the potential to play a role in screening BRCA patients undergoing breast MRI.

KEY POINT:

• Develop and optimize a rapid magnetic resonance imaging (MRI) screening protocol for pancreatic cancer to be performed in conjunction with breast MRI screening in BRCA mutation positive individuals.

KEYWORDS:

Breast cancer; Early detection of cancer; Magnetic resonance imaging; Pancreatic neoplasm; Screening

PMID:
30689033
DOI:
10.1007/s00330-018-5975-0

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center